Harpoon Therapeutics, Inc. HARP NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

46/100

2/7 Pass

SharesGrow Intrinsic Value

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Harpoon Therapeutics, Inc. (HARP) .

本页证实的标准:

VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+2942.2%).
分析师共识目标价 $700.00 (+2942.2% 上行空间) — 华尔街分析师认为存在显著上行潜力。

SharesGrow 综合评分： 46/100 其中 2/7 项标准通过。

SharesGrow 7-Criteria Score

46/100

SG Score

View full scorecard →

✓

价值

100/100

Price-to-Earnings & upside

Proven by this page

✓

未來

85/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

✗

健康

25/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

41/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — HARP

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率2.39

EV/EBITDA0.0

每股数据

EPS (TTM)$-20.24

每股账面价值$0.00

每股营收$9.62

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

分析师目标价$700.00 (+2942.2%)

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2016	$-1.21	$0.00	$-11.41M	-
2017	$-17.81	$708K	$-16.83M	-2377.1%
2018	$-11.45	$4.75M	$-27.37M	-576.1%
2019	$-23.91	$5.78M	$-52M	-900.1%
2020	$-18.52	$17.44M	$-46.38M	-265.9%
2021	$-51.57	$23.65M	$-166.44M	-703.6%
2022	$-20.24	$31.92M	$-67.14M	-210.4%